All articles tagged with #ro
Serena Williams has publicly shared her weight loss journey using FDA-approved GLP-1 treatments through telehealth platform Ro, emphasizing that her use of the medication was a biological necessity after having kids and not a shortcut, aiming to normalize conversations around medical weight loss solutions.
Serena Williams has publicly shared her experience using GLP-1 weight-loss medications through telehealth company Ro, highlighting her 31-pound weight loss postpartum and challenging misconceptions about weight management, while endorsing the drugs and the company's approach.
Ro, a direct-to-consumer health-care startup, has partnered with Eli Lilly to offer more affordable single-dose vials of the weight loss drug Zepbound. This integration allows patients to receive a diagnosis, prescription, and home delivery of Zepbound through Ro's platform, streamlining access to the drug. The vials, available via LillyDirect, are a cash-pay product and cost significantly less than the autoinjector form, making them more accessible to uninsured patients. This move aims to expand access to branded Zepbound and counter the rise of cheaper compounded versions.